Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87107 refers to a laboratory procedure specifically designed for the culture and definitive identification of fungi, particularly molds. This test is crucial in the diagnostic process for fungal or yeast infections, as it allows healthcare professionals to accurately identify the specific organism responsible for the infection. The procedure involves growing pure isolates of yeast and/or filamentous fungi in a controlled laboratory environment. Once cultured, the identification of these organisms is achieved through a combination of macroscopic and microscopic examination, which assesses the physical characteristics of the fungi. Additionally, advanced techniques such as nucleic acid hybridization probes, D2rDNA gene sequencing, real-time polymerase chain reaction (RT-PCR), or MALDI-TOF mass spectrometry are employed to confirm the identity of the pathogens. It is important to note that each organism identified in the culture is reported separately using this code. In cases where multiple colonies are present, the code may be reported multiple times to reflect the number of distinct organisms identified. For the identification of yeast, a different code, 87106, is utilized, while 87107 is specifically reserved for mold identification.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87107 is indicated for use in the diagnosis and management of various fungal or yeast infections. The following conditions may warrant the performance of this laboratory test:
The procedure for CPT® Code 87107 involves several critical steps to ensure accurate identification of mold organisms. The following outlines the procedural steps:
Post-procedure care following the culture and identification of molds typically involves the interpretation of results by a healthcare provider. The identification of the specific mold can significantly influence treatment decisions, including the choice of antifungal therapy. Patients may be monitored for response to treatment, and follow-up cultures may be performed if necessary to ensure the effectiveness of the therapy. Additionally, healthcare providers may consider the patient's clinical history and any underlying conditions that could affect the management of the identified fungal infection.
| Short Descr | FUNGI IDENTIFICATION MOLD | Medium Descr | CULTURE FUNGI DEFINITIVE ID EACH ORGANISM MOLD | Long Descr | Culture, fungi, definitive identification, each organism; mold | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 4 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | Q4 | Service for ordering/referring physician qualifies as a service exemption | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | GZ | Item or service expected to be denied as not reasonable and necessary | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 2001-01-01 | Added | First appearance in code book in 2001. |
Get instant expert-level medical coding assistance.